Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UroGen Pharma (URGN) Raw Materials: 2020-2021

Historic Raw Materials for UroGen Pharma (URGN) over the last 1 years, with Mar 2021 value amounting to $2.4 million.

  • UroGen Pharma's Raw Materials was N/A to $2.4 million in Q1 2021 from the same period last year, while for Mar 2021 it was $2.4 million, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2020, which is N/A change from last year.
  • Latest data reveals that UroGen Pharma reported Raw Materials of $2.4 million as of Q1 2021, which was up 132.45% from $1.1 million recorded in Q4 2020.
  • Over the past 5 years, UroGen Pharma's Raw Materials peaked at $2.4 million during Q1 2021, and registered a low of $893,000 during Q2 2020.
  • Its 2-year average for Raw Materials is $1.3 million, with a median of $989,000 in 2020.